Dr. Kaitlyn Elizabeth McSurdy, MD

Dr. McSurdy practices at Temple University Hospital in Philadelphia, Pennsylvania, part of Temple University.

Dr. McSurdy's NPI, 1831715986, was assigned on June 24, 2020. Dr. McSurdy holds Pennsylvania license MT221816.

Dr. McSurdy's primary practice is Temple University Hospital, at 3401 North Broad Street, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-2000. The NPI Registry lists Dr. McSurdy's practice address as 2450 W Hunting Park Ave, Philadelphia, PA 19129.

Dr. McSurdy's primary practice is Temple University Hospital in Philadelphia, Pennsylvania, part of Temple University. The medical group on file is Temple Faculty Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McSurdy practices. Vendor and product names are available with a free account.

Internal medicine is Dr. McSurdy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. McSurdy is licensed in Pennsylvania.

CMS data shows 15 Medicare services from Dr. McSurdy across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $1,141 for them. Every service was in an office.

CMS counts 34 Medicare patients who saw Dr. McSurdy in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 3.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McSurdy's median patient age at 46, with 50% women.

In 2024, Dr. McSurdy wrote 19 Medicare Part D claims for 12 patients. 89% of them were for generic drugs. They cover 7 drugs, with $882 in total drug cost. In 2022, CMS named 188 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. McSurdy for performance year 2024, reported as part of a group.

CMS Open Payments shows 10 general payments to Dr. McSurdy from 6 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $296.